<div id="readability-page-1">05:23 PM EST, 01/13/2026 (MT Newswires) -- Shattuck Labs ( STTK ) filed a shelf registration statement with US regulators on late Tuesday for the potential sale of up to $200 million in securities, to be offered from time to time.The filing covers common stock, preferred stock, debt securities, warrants and units.The company said the offering proceeds will fund clinical trials, product development, general corporate needs, and potential acquisitions, with unused funds held in safe investments. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

STTK

美國東部時間 2026 年 1 月 13 日下午 5:23（MT Newswires）-- Shattuck Labs（STTK）於週二晚間向美國監管機構提交了一份貨架註冊聲明，計劃出售最多 2 億美元的證券，銷售將不定期進行。該文件涵蓋普通股、優先股、債務證券、認股權證和單位。公司表示，發行所得將用於臨牀試驗、產品開發、一般企業需求和潛在收購，未使用的資金將用於安全投資。MT Newswires 不提供投資建議。未經授權的複製是嚴格禁止的

Shattuck Labs 提交了 2 億美元的混合證券架構申請